Eliquis 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26F9BY7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,321
Award facts
- Contract value 100% obligated
- $34,321.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $34,321.27, awards AmerisourceBergen Drug Corp the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract with the Defense Logistics Agency (DLA). The contract is non-competitive and represents a single delivery order issued on November 17, 2025, with an ultimate completion date of November 18, 2025. Performance will be executed from the awardee's corporate office location in Conshohocken, Pennsylvania. This award is a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving defense and veteran healthcare systems. The company maintains an extensive portfolio of competitively awarded federal contracts with the DLA covering a broad range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This Eliquis delivery order demonstrates the company's ongoing role in supplying brand-name medications to support military healthcare requirements through the DLA's pharmaceutical supply chain, with the potential for similar ordering arrangements under the broader Prime Vendor Global Program framework anticipated for future regional contracts.
Quick answers
Who was awarded contract SPE2DR26F9BY7?
SPE2DR26F9BY7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26F9BY7 worth?
The government has obligated $34,321 on SPE2DR26F9BY7.
Is contract SPE2DR26F9BY7 an order under another contract?
Yes. SPE2DR26F9BY7 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9BY7 competed?
The extent of competition for SPE2DR26F9BY7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award